Saturday 6th May

Session 7: Novel methodologies and technologies in GPCR signaling and Drug Design 
Chairs: Nina Vardjan and Alexei Bondar

09:00-09:30 Dimitrios Stamou (University of Copenhagen, Denmark)
“Visualizing GPCR organization and function at the plasma membrane using Nanoscale High Content Analysis”

09:30-10:00 Ago Rinken (University of Tartu, Estonia)
“The three musketeers studying dynamics of fluorescent ligand binding to GPCRs: challenges and possibilities”

10:00-10:30 Stefan Schulz (7TM antibodies GmbH, Germany)
“Novel applications for phosphosite-specific GPCR antibodies”

10:30-10:50   Gregory Verdon (Sosei Heptares, Cambridge, UK)  
“Structure-based discovery of a novel H4R antagonist with clinical potential for the treatment of atopic  dermatitis”

10:50-11:05    Claudia Llinas del Torrent (Autonomy University of Barcelona, Spain)
“Structural mechanism underlying cross-agonism allosteric effect in GPCR heterodimers” 

Session 8: Computational modeling and AI in signal transduction 

Chairs: Minos Matsoukas and Masha Niv

14:30-15:00 Masha Niv (Hebrew University, Israel)
"Bitter and sweet taste GPCRs"

15:00-15:30 Henri Xhaard  (University of Helsinki, Finland)
“Predicting GPCR-mediated environmental effects using docking simulations”

15:30-15:45 Christos Μatsingos (Queen Mary, University of London, United Kingdom)
“Insights into the activation mechanisms of GPR68”

15:45-16:00 András Dávid Tóth (Semmelweis University, Hungary)
“Ligand dissociation rate determines β-arrestin binding efficacy in endosomes” 

16:00-16:15 Zara Farooq (Queen Mary University of London, UK)
“Identification of a Cannabinoid Receptor 2 allosteric site using computational Modelling and Pharmacological analysis”

16:15-16:30 Minos Matsoukas (University of West Attica, Greece)
“Computational approaches in targeting GPCRs with small molecules or peptides” 

Poster presentations